DUSA Pharmaceuticals Up Almost 8% (DUSA)

DUSA Pharmaceuticals, Inc. DUSA shares are skyrocketing today, gaining 34 cents to $4.87, a gain of 7.5%. DUSA Pharmaceuticals, Inc., a vertically integrated dermatology company, develops and markets Levulan photodynamic therapy (PDT) and other products for common skin conditions in the United States and internationally.